Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (2018)
Attributed to:
MICA: Targeting the RA synovial fibroblast via cyclin dependent kinase inhibition - a phase IIa study
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2018-213378
PubMed Identifier: 29980575
Publication URI: http://europepmc.org/abstract/MED/29980575
Type: Journal Article/Review
Parent Publication: Annals of the Rheumatic Diseases
Issue: 10
ISSN: 0003-4967